Connection
William Janssen to B7-1 Antigen
This is a "connection" page, showing publications William Janssen has written about B7-1 Antigen.
|
|
Connection Strength |
|
 |
|
 |
|
0.075 |
|
|
|
-
Fishman M, Hunter TB, Soliman H, Thompson P, Dunn M, Smilee R, Farmelo MJ, Noyes DR, Mahany JJ, Lee JH, Cantor A, Messina J, Seigne J, Pow-Sang J, Janssen W, Antonia SJ. Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma. J Immunother. 2008 Jan; 31(1):72-80.
Score: 0.075